Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 7
1966 6
1967 6
1968 5
1969 5
1970 1
1971 2
1972 2
1973 1
1974 3
1975 5
1976 2
1977 5
1978 3
1979 4
1980 1
1981 2
1986 2
1987 2
1988 1
1989 1
1990 2
1993 1
2000 1
2001 1
2002 1
2003 3
2004 1
2005 6
2006 2
2007 2
2008 5
2009 4
2010 2
2011 2
2012 2
2013 5
2014 1
2015 1
2016 5
2017 2
2018 5
2019 2
2020 6
2021 16
2022 15
2023 7
2024 13
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Results by year

Filters applied: . Clear all
Page 1
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.
Iaffaldano P, Lucisano G, Guerra T, Paolicelli D, Portaccio E, Inglese M, Foschi M, Patti F, Granella F, Romano S, Cavalla P, De Luca G, Gallo P, Bellantonio P, Gallo A, Montepietra S, Di Sapio A, Vianello M, Quatrale R, Spitaleri D, Clerici R, Torri Clerici V, Cocco E, Brescia Morra V, Marfia GA, Boccia VD, Filippi M, Amato MP, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: vianello m. Ann Clin Transl Neurol. 2024 Aug;11(8):2008-2015. doi: 10.1002/acn3.52118. Epub 2024 Jul 5. Ann Clin Transl Neurol. 2024. PMID: 38970214 Free PMC article.
Editorial: Implicit social cognition: malleability and change.
Marini M, Sabin J, O'Shea B, Vianello M. Marini M, et al. Among authors: vianello m. Front Psychol. 2024 Sep 11;15:1475986. doi: 10.3389/fpsyg.2024.1475986. eCollection 2024. Front Psychol. 2024. PMID: 39323586 Free PMC article. No abstract available.
Multiple Sclerosis Progression and Relapse Activity in Children.
Iaffaldano P, Portaccio E, Lucisano G, Simone M, Manni A, Guerra T, Paolicelli D, Betti M, De Meo E, Pastò L, Razzolini L, Rocca MA, Ferrè L, Brescia Morra V, Patti F, Zaffaroni M, Gasperini C, De Luca G, Ferraro D, Granella F, Pozzilli C, Romano S, Gallo P, Bergamaschi R, Coniglio MG, Lus G, Vianello M, Banfi P, Lugaresi A, Totaro R, Spitaleri D, Cocco E, Di Palma F, Maimone D, Valentino P, Torri Clerici V, Protti A, Maniscalco GT, Salemi G, Pesci I, Aguglia U, Lepore V, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register. Iaffaldano P, et al. Among authors: vianello m. JAMA Neurol. 2024 Jan 1;81(1):50-58. doi: 10.1001/jamaneurol.2023.4455. JAMA Neurol. 2024. PMID: 38010712 Free PMC article.
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study.
Novi G, Bovis F, Sciolla C, Frau J, Minetti M, Napoli F, Vianello M, Greco G, Sechi E, Bellomo A, Garelli P, Spiezia AL, Fantozzi R, Schirò G, Ghezzi L, Zecca C, Signoriello E, Brambilla L, Lucchini M, Bonavita S, Schiavetti I, Malentacchi M, Cocco E, Franceschini A, Mataluni G, Gastaldi M, Rolando A, Solla P, Cellerino M, Abbadessa G, Lanzillo R, Di Sapio A, Uccelli A, Sormani MP. Novi G, et al. Among authors: vianello m. CNS Drugs. 2025 Jul;39(7):693-705. doi: 10.1007/s40263-025-01191-7. Epub 2025 May 29. CNS Drugs. 2025. PMID: 40442445
Trisomy 22.
Vianello MG, Bonioli E. Vianello MG, et al. J Genet Hum. 1975 Oct;23 SUPPL:133. J Genet Hum. 1975. PMID: 55463 No abstract available.
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosis.
Portaccio E, Betti M, De Meo E, Pastò L, Razzolini L, Patti F, Brescia Morra V, De Luca G, Pozzilli C, Tortorella C, Cocco E, Salemi G, Ferraro D, Vianello M, Lus G, Lugaresi A, Inglese M, Tedeschi G, Montepietra S, Di Sapio A, Zaffaroni M, Iaffaldano P, Simone M, Filippi M, Trojano M, Amato MP. Portaccio E, et al. Among authors: vianello m. Mult Scler. 2025 Jul;31(8):985-994. doi: 10.1177/13524585251345317. Epub 2025 Jun 19. Mult Scler. 2025. PMID: 40534483
Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.
Zanghì A, Copetti M, Avolio C, Paolicelli D, Romeo MAL, Patti F, De Luca G, Amato MP, Galgani S, Sola P, Salemi G, Gallo P, Granella F, Romano S, Zaffaroni M, Bergamaschi R, Pozzilli C, Lus G, Vianello M, Trojano M, D'Amico E; Italian Multiple Sclerosis register. Zanghì A, et al. Among authors: vianello m. J Neurol Neurosurg Psychiatry. 2025 Oct 15;96(11):1061-1069. doi: 10.1136/jnnp-2025-335958. J Neurol Neurosurg Psychiatry. 2025. PMID: 40518265 Free PMC article.
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register].
Ponzio M, Battaglia MA, Trojano M, Salivetto M, D'Ettorre A, Corrado D, Paletta P, Lepore V, Mosconi P; Comitato Scientifico del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete dei centri del Registro Italiano Sclerosi Multipla e Patologie Correlate; Rete degli assistenti di ricerca del Registro Italiano Sclerosi Multipla e Patologie Correlate. Ponzio M, et al. Epidemiol Prev. 2024 Jul-Oct;48(4-5):361-374. doi: 10.19191/EP24.4-5.A734.074. Epidemiol Prev. 2024. PMID: 39329242 Free article. Italian.
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Chisari CG, Aguglia U, Amato MP, Bergamaschi R, Bertolotto A, Bonavita S, Morra VB, Cavalla P, Cocco E, Conte A, Cottone S, De Luca G, Di Sapio A, Filippi M, Gallo A, Gasperini C, Granella F, Lus G, Maimone D, Maniscalco GT, Marfia G, Moiola L, Paolicelli D, Pesci I, Ragonese P, Rovaris M, Salemi G, Solaro C, Totaro R, Trojano M, Vianello M, Zaffaroni M, Lepore V, Patti F; Italian MS Register Study Group. Chisari CG, et al. Among authors: vianello m. Neurotherapeutics. 2024 Jul;21(4):e00363. doi: 10.1016/j.neurot.2024.e00363. Epub 2024 May 7. Neurotherapeutics. 2024. PMID: 38714462 Free PMC article.
176 results